Dare Bioscience, Inc. — Director's Dealing 2014

Jul 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-07-17

Reporting Person: Roberts Karen Lynn (Sr VP Finance & Administrat)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-17	Stock Option (right to buy)	$4.98	A	20100	Acquired	2024-07-16	Common Stock (20100)	Direct

Footnotes

F1: This option was granted on July 17, 2014. The option vests as to 2.08333% of the underlying shares monthly from June 24, 2014 through and including June 24, 2018.